AIM

#5038
AIM ImmunoTech Inc.
0.5800 USD
+7.57%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
0.5701
0.5840
1年のレンジ
0.5060
20.3500
1日の変化
+7.57%
月次変化
-22.67%
6か月変化
-77.78%
1年の変化
-93.18%
以前の終値
0.5392
始値
0.5701
Bid
Ask
安値
0.5701
High
0.5840
ボリューム
22
チャート全体を表示

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 4.7257 M
  • Employee 21
  • Founded N/A
  • CEO N/A
  • Website www.aimimmuno.com
  • Headquarter Delaware, United States
  • FIGI BBG000JL6Z80
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.13
売上高対価格比率
20.76

AIM ImmunoTech Inc

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

ニュース